Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts’ Top Healthcare Picks: LENZ Therapeutics (LENZ), CVS Health (CVS)

Tipranks - Tipranks - Wed Mar 25, 2:32PM CDT

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on LENZ Therapeutics (LENZ) and CVS Health (CVS) with bullish sentiments.

Claim 30% Off TipRanks Premium

LENZ Therapeutics (LENZ)

In a report released today, Lachlan Hanbury Brown from William Blair maintained a Buy rating on LENZ Therapeutics. The company’s shares closed last Tuesday at $9.36.

According to TipRanks.com, Brown is a 3-star analyst with an average return of 2.7% and a 27.5% success rate. Brown covers the Healthcare sector, focusing on stocks such as Apellis Pharmaceuticals, Tarsus Pharmaceuticals, and Viridian Therapeutics. ;'>

The word on The Street in general, suggests a Strong Buy analyst consensus rating for LENZ Therapeutics with a $49.67 average price target.

See today’s best-performing stocks on TipRanks >>

CVS Health (CVS)

Leerink Partners analyst Michael Cherny reiterated a Buy rating on CVS Health today and set a price target of $98.00. The company’s shares closed last Tuesday at $73.08.

According to TipRanks.com, Cherny is a 4-star analyst with an average return of 3.9% and a 54.7% success rate. Cherny covers the Healthcare sector, focusing on stocks such as Hims & Hers Health, Envista Holdings, and Cardinal Health. ;'>

Currently, the analyst consensus on CVS Health is a Strong Buy with an average price target of $96.14, a 35.4% upside from current levels. In a report issued on March 12, Bernstein also upgraded the stock to Buy with a $94.00 price target.

Read More on LENZ:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).